We are gradually migrating to our new home, the HDR UK Phenotype Library.
CCU000 COVID-19
Metadata
| Name | CCU000 COVID-19 |
| Type | Disease or Syndrome |
| Group | Disease or Syndrome |
| Data Sources |
|
| Clinical Terminologies |
SNOMED-CT ICD-10 |
| Codelists | covid_impact_ccu000_England_COVID19_ICD10.csv covid_impact_ccu000_England_COVID19_SNOMEDCT.csv |
| Valid Event Data Range | 31/01/2020 - 31/10/2020 |
| Sex |
Female Male |
| Authors | Angela Wood, Rachel Denholm, Sam Hollings, Jennifer Cooper, Samantha Ip,Venexia Walker, Spiros Denaxas, Ashley Akbari, Amitava Banerjee, William Whiteley, Alvina Lai, Jonathan Sterne, Cathie Sudlow, CVD-COVID-UK consortium |
| Agreement Date | 29 Mar 2020 |
| Version (UUID) | Revision 1 (COVID-IMPACT) |
Phenotypes
England hospitalization EHR: COVID-19 diagnosis
| icd10code | icd10term | type |
|---|---|---|
| U071 | COVID-19, virus identified | 1 |
| U072 | COVID-19, virus not identified | 1 |
England primary care EHR: COVID-19 diagnosis
| conceptId | term | flag | type |
|---|---|---|---|
| 1321181000000108 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 record extraction simple reference set (foundation metadata concept) | Clinically confirmed | 1 |
| 1321201000000107 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 health issues simple reference set (foundation metadata concept) | Clinically confirmed | 1 |
| 1321191000000105 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 procedures simple reference set (foundation metadata concept) | Clinically confirmed | 1 |
| 1321331000000107 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 total immunoglobulin in serum (observable entity) | Lab confirmed historic | 0 |
| 1321301000000101 | Severe acute respiratory syndrome coronavirus 2 ribonucleic acid qualitative existence in specimen (observable entity) | Lab confirmed incidence | 1 |
| 1321811000000105 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin A qualitative existence in specimen (observable entity) | Lab confirmed historic | 0 |
| 1321311000000104 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin M qualitative existence in specimen (observable entity) | Lab confirmed historic | 0 |
| 1321321000000105 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin G qualitative existence in specimen (observable entity) | Lab confirmed historic | 0 |
| 1322871000000109 | Severe acute respiratory syndrome coronavirus 2 antibody detection result positive (finding) | Lab confirmed historic | 0 |
| 1240751000000100 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1321551000000106 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin M detected (finding) | Lab confirmed historic | 0 |
| 1321241000000105 | Cardiomyopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240411000000107 | Ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (substance) | Lab confirmed incidence | 1 |
| 1240421000000101 | Serotype severe acute respiratory syndrome coronavirus 2 (qualifier value) | Lab confirmed historic | 0 |
| 1240391000000107 | Antigen of severe acute respiratory syndrome coronavirus 2 (substance) | Lab confirmed incidence | 1 |
| 1008541000000105 | Coronavirus ribonucleic acid detection assay (observable entity) | Lab confirmed incidence | 1 |
| 1029481000000103 | Coronavirus nucleic acid detection assay (observable entity) | Lab confirmed incidence | 1 |
| 1300631000000101 | Coronavirus disease 19 severity score (observable entity) | Clinically confirmed | 1 |
| 1300671000000104 | Coronavirus disease 19 severity scale (assessment scale) | Clinically confirmed | 1 |
| 121973000 | Measurement of coronavirus antibody (procedure) | Lab confirmed historic | 0 |
| 120814005 | Coronavirus antibody (substance) | Lab confirmed historic | 0 |
| 186747009 | Coronavirus infection (disorder) | Clinically confirmed | 1 |
| 1321211000000109 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 presenting complaints simple reference set (foundation metadata concept) | Clinically confirmed | 1 |
| 1300731000000106 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed using clinical diagnostic criteria (situation) | Clinically confirmed | 1 |
| 1321351000000100 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin M in serum (observable entity) | Lab confirmed historic | 0 |
| 1321801000000108 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin A in serum (observable entity) | Lab confirmed historic | 0 |
| 1321341000000103 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin G in serum (observable entity) | Lab confirmed historic | 0 |
| 1300721000000109 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation) | Lab confirmed unclear | 1 |
| 1240511000000106 | Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure) | Lab confirmed incidence | 1 |
| 1240541000000107 | Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1322781000000102 | Severe acute respiratory syndrome coronavirus 2 antigen detection result positive (finding) | Lab confirmed incidence | 1 |
| 1240581000000104 | Severe acute respiratory syndrome coronavirus 2 ribonucleic acid detected (finding) | Lab confirmed incidence | 1 |
| 1321761000000103 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin A detected (finding) | Lab confirmed historic | 0 |
| 1321541000000108 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin G detected (finding) | Lab confirmed historic | 0 |
| 1240571000000101 | Gastroenteritis caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240561000000108 | Encephalopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240521000000100 | Otitis media caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240531000000103 | Myocarditis caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240551000000105 | Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder) | Clinically confirmed | 1 |
| 1240741000000103 | Severe acute respiratory syndrome coronavirus 2 serology (observable entity) | Lab confirmed historic | 0 |
| 1240401000000105 | Antibody to severe acute respiratory syndrome coronavirus 2 (substance) | Lab confirmed historic | 0 |
| 1300681000000102 | Assessment using coronavirus disease 19 severity scale (procedure) | Clinically confirmed | 1 |
| 1240381000000105 | Severe acute respiratory syndrome coronavirus 2 (organism) | Clinically confirmed | 1 |
Publication
Angela Wood, Rachel Denholm, Sam Hollings, Jennifer Cooper, Samantha Ip,Venexia Walker, Spiros Denaxas, Ashley Akbari, Amitava Banerjee, William Whiteley, Alvina Lai, Jonathan Sterne, Cathie Sudlow, CVD-COVID-UK consortium. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England data resource BMJ 2021; 373 :n826 doi:10.1136/bmj.n826